Holdings
BIOS Capital Management, LP
As of Jun 30, 2026, BIOS Capital Management, LP reported 6 positions worth US$41.7M. Largest: Actuate Therapeutics, Inc., Opus Genetics, Inc. and Cognition Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Actuate Therapeutics, Inc. | 10M | US$15.4M | no change | Jun 30, 2026 |
| Opus Genetics, Inc. | 3.68M | US$15.1M | no change | Jun 30, 2026 |
| Cognition Therapeutics, Inc. | 6M | US$6.9M | no change | Jun 30, 2026 |
| Rein Therapeutics, Inc. | 2.98M | US$3.1M | +1M | Jun 30, 2026 |
| Lantern Pharma Inc. | 249K | US$1.04M | −615K | Jun 30, 2026 |
| In8bio, Inc. | 80,957 | US$114K | −86,848 | Jun 30, 2026 |